Convalescent plasma is a suggested treatment for Coronavirus disease 2019 (Covid-19),
but its efficacy is uncertain. We aimed to evaluate whether the use of convalescent plasma is …

The pandemic COVID-19 has spread widely throughout the globe and has been responsible
for millions of deaths worldwide. Recently, it has been identified that there is no specific and …

Introduction When the COVID-19 pandemic struck no specific therapies were available and
many turned to COVID-19 convalescent plasma (CCP), a form of antibody therapy. The …

Currently, there are no approved specific antiviral agents for 2019 novel coronavirus
disease (COVID-19). In this study, ten severe patients confirmed by real-time viral RNA test …

Evaluating the effect of convalescent plasma (CP) on some cytokine storm indices in severe
COVID-19 patients. Totally, 62 patients were randomly assigned into two groups for this …

Convalescent plasma can provide passive immunity during viral outbreaks, but the benefit is
uncertain for the treatment of novel coronavirus disease 2019 (COVID‐19). Our goal is to …

The discovery of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and the
outbreak of coronavirus disease 2019 (COVID‐19) are causing public health emergencies …

According to statistics by John Hopkins University (JHU) of Medicine, SARS-CoV-2
viruseinduced coronavirus disease 2019 (COVID-19) has, to date (April 22, 2020), infected …

Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life
of several hundred thousand worldwide. However, so far no approved vaccine or drug …

Objectives To describe the humoral immune feature of patients with coronavirus disease
2019 (COVID-19). Methods The levels of total immunoglobulins (IgG, IgM, IgA, and IgE) …